2012
Natural Antibodies and Atherosclerosis; pp.
Tsiantoulas D,
Binder CJ.
289-304 in Inflammation and Atherosclerosis; Springer; Edited by Georg Wick & Cecilia Grundtman.
2012
Animal Models of Sepsis.
Knapp S.
Section Editor of this issue and Editorial. Drug Discovery Today – Disease Models Jan 2012.
2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Georg E Winter,
Uwe Rix,
Scott M Carlson,
Karoline V Gleixner,
Florian Grebien,
Manuela Gridling,
André C Müller,
Florian P Breitwieser,
Martin Bilban,
Jacques Colinge,
Peter Valent,
Keiryn L Bennett,
Forest M White,
Giulio Superti-Furga.
Nat Chem Biol. 2012 Nov;8(11):905-912. doi: 10.1038/nchembio.1085. Epub 2012 Sep 30.
2012
A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses.
Litvak V,
Ratushny AV,
Lampano AE,
Schmitz F,
Huang AC,
Raman A,
Rust AG,
Bergthaler A,
Aitchison JD,
Aderem A.
Nature. 2012 Oct 18;490(7420):421-5.
2012
BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
Oliver Hantschel,
Wolfgang Warsch,
Eva Eckelhart,
Ines Kaupe,
Florian Grebien,
Kay-Uwe Wagner,
Giulio Superti-Furga,
Veronika Sexl.
Nat Chem Biol. 2012 Jan 29;8(3):285-93. doi: 10.1038/nchembio.775.
2011
TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal Panton-Valentine leukocidin in vivo.
Zivkovic A,
Sharif O,
Stich K,
Doninger B,
Biaggio M,
Colinge J,
Bilban M,
Mesteri I,
Hazemi P,
Lemmens-Gruber R,
Knapp S.
J Immunol. 2011 Feb 1;186(3):1608-17.
2011
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.
Zimprich A,
Benet-Pages A,
Struhal W,
Graf E,
Eck SH,
Offman MN,
Haubenberger D,
Spielberger S,
Schulte EC,
Lichtner P,
Rossle SC,
Klopp N,
Wolf E,
Seppi K,
Pirker W,
Presslauer S,
Mollenhauer B,
Katzenschlager R,
Foki T,
Hotzy C,
Reinthaler E,
Harutyunyan A,
Kralovics R,
Peters A,
Zimprich F,
Brucke T,
Poewe W,
Auff E,
Trenkwalder C,
Rost B,
Ransmayr G,
Winkelmann J,
Meitinger T,
Strom TM.
Am J Hum Genet. 2011 Jul 15;89(1):168-75.
2011
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.
Wool GD,
Cabana VG,
Lukens J,
Shaw PX,
Binder CJ,
Witztum JL,
Reardon CA,
Getz GS.
FASEB J. 2011 Jan;25(1):290-300.
2011
An integrated chemical biology approach identifies specific vulnerability of Ewing’s sarcoma to combined inhibition of Aurora kinases A and B.
Winter GE,
Rix U,
Lissat A,
Stukalov A,
Mullner MK,
Bennett KL,
Colinge J,
Nijman SM,
Kubicek S,
Kovar H,
Kontny U,
Superti-Furga G.
Mol Cancer Ther. 2011 Oct;10(10):1846-56.
2011
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress.
Weismann D,
Hartvigsen K,
Lauer N,
Bennett KL,
Scholl HP,
Charbel Issa P,
Cano M,
Brandstatter H,
Tsimikas S,
Skerka C,
Superti-Furga G,
Handa JT,
Zipfel PF,
Witztum JL,
Binder CJ.
Nature. 2011 Oct 6;478(7367):76-81.
